Aloe Vera's Anticancer Properties

For centuries, Aloe vera has been celebrated in alternative medicine as a powerful plant remedy for wounds, burns, and skin care. But emerging scientific research now points toward a more profound application: Aloe and its compounds may play a role in the fight against cancer. This post explores recent findings on how Aloe's active compounds interact with cancer cells, focusing on evidence from laboratory and animal studies.

Key Findings at a Glance

• Aloe and its extracts exhibit significant anticancer and cytotoxic effects on various cancer cells in laboratory and animal studies.
• Several bioactive compounds in Aloe, such as Aloin, Aloe-emodin, and Alomicin, demonstrate growth-inhibitory, anti-proliferative, and apoptosis-inducing properties against cancer cells.
• Aloe compounds can inhibit angiogenesis (the formation of new blood vessels that feed tumors) and reduce cancer-related inflammation.

Breaking Down the Science

1. Growth-Inhibitory Effects on Cancer Cells

Studies using animal models have shown that Aloe vera can slow or even inhibit the growth of certain cancers. For example:

• Dichloromethane extracts from Cape Aloe (mainly Aloe ferox) have stopped tumor growth in rats with pleural tumors derived from hepatoma cells.
• These extracts also reduce DNA synthesis and cause cell cycle arrest (particularly in the G1 phase), meaning cancer cells can't multiply as effectively.

2. Cytotoxic Compounds in Aloe

Aloin, one of Aloe’s major components, belongs to the anthracycline family. Interestingly, modern oncology already uses other anthracyclines, like doxorubicin, to treat various cancers including breast, ovarian, and lung.

• Aloin shows strong cytotoxicity in lab tests on breast cancer cells, particularly those lacking the ErbB-2 receptor.
• Another compound, emodin, is highly effective at killing human myeloma cells and other cancer lines.

3. Promoting Cancer Cell Death (Apoptosis)

Many Aloe compounds, including aloe-emodin, trigger “apoptosis”—a self-destruct process that naturally removes damaged or cancerous cells.

• Aloe leaf extracts (especially from Aloe arborescens) showed remarkable anti-proliferative effects in several cancer cell types, including glioblastoma and myeloma.
• Aloe-emodin has been found to stop the spread and trigger apoptosis across a wide spectrum of cancer cells (colon, oral, gastric, cervical, lung, prostate, bladder, and more).

4. Fighting Blood and Lymphatic Cancers

The evidence isn’t limited to solid tumors. Aloe-emodin and other compounds:

• Demonstrate anti-proliferative and apoptosis-inducing activity in leukemia and lymphoma cells, including those resistant to multiple drugs.
• Alomicin, isolated from Aloe arborescens, powerfully inhibited sarcoma and hepatoma cell growth in mice.

5. Impact on Tumor Blood Supply (Anti-Angiogenesis)

Tumors need a blood supply to grow and metastasize. Aloe’s compounds attack this vulnerability:

• Aloe-emodin and aloin have been shown to inhibit the formation of blood vessels that support tumors. This was evident in mouse models, where Aloe vera gel reduced new vessel formation.
• Aloin can block STAT3 activation in colorectal cancer, curbing tumor blood vessel growth.

6. Reducing Cancer’s Link to Chronic Inflammation

Chronic inflammation is a major factor in cancer progression. Tumor environments typically bristle with inflammatory signals that spur growth, spread, and genetic instability.

• Aloe’s extracts and constituents have demonstrated a strong ability to suppress inflammation in laboratory models, reducing the production of molecules that can nourish tumors.

What Does This Mean for Alternative Medicine?

While Aloe is no miracle cancer cure, new research provides a biochemical basis for its traditional use and raises exciting questions for future therapies. Its array of active compounds appears to work against cancer cells through multiple mechanisms:

• Directly killing cancer cells (cytotoxicity)
• Halting their growth (anti-proliferative)
• Forcing them to undergo apoptosis
• Starving them by blocking blood vessel growth (anti-angiogenesis)
• Dampening surrounding inflammation that helps tumors thrive

Safety, Limitations, and Next Steps

It’s important to note:

• Most evidence comes from laboratory and animal studies. Large-scale human trials are still needed before Aloe or its extracts can be recommended as cancer treatments.
• Dose, preparation method, and source species all matter. Not all Aloe products are equal in their bioactive compound content.
• Self-treatment with Aloe supplements for cancer is not recommended without medical supervision.

The Bottom Line

The science supports what alternative medicine has long suggested: Aloe vera, with its diverse range of bioactive compounds, has real potential in combating cancer cells. These findings add credibility to the use of Aloe for those seeking supportive therapy—but underscore the need for well-designed clinical trials in humans.

If you’re considering integrating Aloe into your wellness routine, especially if you are undergoing cancer treatment, always consult your healthcare provider or oncologist.

Aloe Vera and Phase II Liver Detoxification

Aloe vera contains a powerful combination of phytochemicals, antioxidants, and enzymes that support liver function. What truly sets aloe vera apart is its unique ability to induce phase II detoxification pathways.

How does aloe vera help?

• Rich in Antioxidants: Aloe vera offers an array of antioxidants such as vitamins A, C, and E that help reduce oxidative stress on liver cells.
• Boosts Glutathione Production: Compounds in aloe vera have been shown to elevate glutathione levels, a critical antioxidant involved in phase II detoxification. Glutathione attaches to toxins and prepares them for elimination.
• Sulfur-containing Molecules: Aloe vera is rich in bioavailable sulfur compounds. These molecules enhance important phase II enzyme systems, making toxin neutralization and excretion more efficient.
• Modulates Detox Enzymes: Research indicates that aloe vera can stimulate the production of key enzymes that drive the phase II process, such as glutathione S-transferase and glucuronyl transferase.

Additional Health Benefits of Aloe Vera

While aloe vera is a champion for liver health, it offers more than detoxification:

• Digestive Support: Aloe is soothing for the gastrointestinal tract and can help reduce inflammation, support regularity, and improve nutrient absorption.
• Blood Sugar Balance: Early studies suggest aloe vera may help maintain healthy blood sugar levels.
• Immunity Boost: The plant’s polysaccharides and natural enzymes provide gentle support for immune function.

 

Sources

Akindele AJ, Adeyemi OO (2007). "Cytotoxic activity of aloin and aloe-emodin from Aloe vera on in vitro cancer cell lines." Afr J Tradit Complement Altern Med.

Saidi K, Zhang S, Chen Z et al. (2019). "Cape aloe extract inhibits tumor growth and induces cell cycle arrest in rat models with malignant pleural effusion." BMC Complement Altern Med.

Suboj P, Babykutty S, Srinivas P, Gopala S. (2012). "Potential role of emodin as anti-cancer agent." Cancer Lett.

Huang Q, Lu G, Shen HM, et al. (2007). "Anti-cancer properties of anthraquinones from rhubarb." Med Res Rev.

Surjushe A, Vasani R, Saple DG. (2008). "Aloe vera: A short review." Indian J Dermatoly

Zhai J, et al. (2019). "Aloin inhibits angiogenesis through suppressing STAT3 activation in colorectal cancer." Int J Biol Sci.

Radha MH, Laxmipriya NP (2015). "Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review." J Tradit Complement Med.

Grimaudo S, et al. (1997). "Induction of apoptosis and cell cycle arrest by aloe-emodin in human myeloma cells." Br J Haematol.

Zapata-Sudo G, Sudo RT, et al. (1997). "Anticancer activity of alomicin isolated from Aloe arborescens." Planta Med.

Yin Z, Zhang W, Feng F. (2013). "Aloe-emodin and aloin induce antiangiogenesis via VEGF pathway in mouse models." Phytother Res.

Park SY, Kim HS, Cho EK, et al. (2011). "Aloe vera suppresses inflammatory responses by blocking NF-kB pathway in cell models." J Ethnopharmacol